Pain management options after lumbar discectomy surgery
Fluoroscopy-Guided Retrolaminar Block Versus Local Wound Infiltration for Post Lumbar Discectomy Analgesia: A Double-Blinded, Randomized Controlled Trial
This study is testing two different ways to manage pain after back surgery to see which one helps patients feel better and recover faster.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 21 Years to 64 Years |
| Sex | All |
| Sponsor | Zagazig University Government |
| Locations | 1 site (Zagazig) |
| Trial ID | NCT06869889 on ClinicalTrials.gov |
What this trial studies
This study compares two methods of pain management following lumbar discectomy surgeries: the retrolaminar block and local wound infiltration. Lumbar discectomy is often performed on patients with herniated discs who have not responded to conservative treatments, but it can lead to significant postoperative pain. The study aims to determine which method provides better pain relief, reduces opioid use, and improves recovery times. By evaluating these techniques, the research seeks to enhance patient outcomes and minimize complications associated with opioid use.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for elective surgical decompression of a single-level herniated lumbar disc.
Not a fit: Patients who are opioid-dependent, have known hypersensitivity to bupivacaine, or have diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing lumbar discectomy, reducing reliance on opioids.
How similar studies have performed: Other studies have shown promising results with regional anesthetic techniques for pain management in spine surgeries, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Elective surgical decompression of single-level herniated lumbar disc. Exclusion Criteria: * Opioid-dependent patients. * Known hypersensitivity to bupivacaine. * Diabetic patients. * Uncooperative patient or with altered mental status. * Previous spine surgery.
Where this trial is running
Zagazig
- Zagazig university hospital — Zagazig, Egypt (Recruiting)
Study contacts
- Study coordinator: Mohamed Gaber, MD
- Email: mgmelsayed@medicine.zu.edu.eg
- Phone: 011118851696
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.